Together, these results suggest that Myr-NE treatment results in efficient inhibition of PAM proteins and VEGFR2 accompanied by significant downregulation of HIF-1α, Ki67, and MMP9 proteins, effectively reducing the tumor proliferation in TNBC xenografts. The gene discussed is KDR; the disease is neoplasm.